Skip to main content
Veterinary Medicines

CAPIZOL SOLUTION BUVABLE

Authorised
  • Levamisole hydrochloride

Product identification

Medicine name:
CAPIZOL SOLUTION BUVABLE
Active substance:
  • Levamisole hydrochloride
Target species:
  • Cattle
  • Pig
  • Sheep
  • Poultry
Route of administration:
  • Oral use

Product details

Active substance and strength:
  • Levamisole hydrochloride
    18.00
    milligram(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Oral solution
Withdrawal period by route of administration:
  • Oral use
    • Cattle
      • Meat and offal
        3
        day
      • Milk
        no withdrawal period
    • Pig
      • Meat and offal
        3
        day
    • Sheep
      • Meat and offal
        3
        day
      • Milk
        no withdrawal period
    • Poultry
      • Meat and offal
        3
        day
      • Eggs
        no withdrawal period
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QP52AE01
Authorisation status:
  • Valid
Authorised in:
  • France
Available in:
  • France
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Virbac
Marketing authorisation date:
Manufacturing sites for batch release:
  • Virbac
  • FC France S.A.S.
Responsible authority:
  • French Agency For Food, Environmental And Occupational Health & Safety
Authorisation number:
  • FR/V/6693705 6/1992
Date of authorisation status change:

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
French (PDF)
Published on: 19/03/2025

Package Leaflet and Labelling

This document does not exist in this language (English). You can find it in another language below.
French (PDF)
Published on: 19/03/2025
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."